First Time Loading...

RaQualia Pharma Inc
TSE:4579

Watchlist Manager
RaQualia Pharma Inc Logo
RaQualia Pharma Inc
TSE:4579
Watchlist
Price: 601 JPY -1.31% Market Closed
Updated: May 8, 2024

RaQualia Pharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RaQualia Pharma Inc
Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
RaQualia Pharma Inc
TSE:4579
Revenue
¥1.9B
CAGR 3-Years
20%
CAGR 5-Years
21%
CAGR 10-Years
24%
Takeda Pharmaceutical Co Ltd
TSE:4502
Revenue
¥4.2T
CAGR 3-Years
9%
CAGR 5-Years
19%
CAGR 10-Years
10%
Daiichi Sankyo Co Ltd
TSE:4568
Revenue
¥1.5T
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
4%
Otsuka Holdings Co Ltd
TSE:4578
Revenue
¥2T
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Revenue
¥1.1T
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Revenue
¥1.9T
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
6%

See Also

What is RaQualia Pharma Inc's Revenue?
Revenue
1.9B JPY

Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Revenue amounts to 1.9B JPY.

What is RaQualia Pharma Inc's Revenue growth rate?
Revenue CAGR 10Y
24%

Over the last year, the Revenue growth was -35%. The average annual Revenue growth rates for RaQualia Pharma Inc have been 20% over the past three years , 21% over the past five years , and 24% over the past ten years .